PETS
PetMed Express, Inc.
PETS trails on the overall score without a compensating advantage in the available component scores.
UNH
UnitedHealth Group Incorporated
UNH has the edge over PETS overall, supported by lower modeled downside and stronger modeled upside.
PETS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Weak | |
| Strong |
PETS's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
PETS PE Valuation
PETS has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
PETS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect PETS's losses to grow, with revenue declining.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
UNH has the edge over PETS on the outlook, with more favorable earnings and revenue expectations.
PETS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.27 | +$1.38 |
| Q2 2026 | -$1.37 | +$0.76 |
| Q1 2026 | -$2.74 | -$2.44 |
| Q4 2025 | -$3.12 | -15700% |
| Q3 2025 | -$2.65 | -$2.60 |
| Q2 2025 | -$2.13 | -$2.00 |
| Q1 2025 | -$0.30 | +$0.07 |
| Q4 2024 | $0.02 | +$0.17 |
PETS lost $1.27 per share over the past year, a smaller loss than the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over PETS on earnings quality, reporting a profit while its opponent remains loss making.
PETS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $35.8M | -19% |
| Q2 2026 | $41M | -20% |
| Q1 2026 | $42.8M | -16% |
| Q4 2025 | $40.7M | -23% |
| Q3 2025 | $44.4M | -26% |
| Q2 2025 | $51.2M | -25% |
| Q1 2025 | $50.8M | -24% |
| Q4 2024 | $53M | -19% |
PETS's revenue has slid since its 2020 peak: $36M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -18% | +0.9 points |
| Q2 2026 | -15% | +52 points |
| Q1 2026 | -13% | -1.4 points |
| Q4 2025 | -26% | -25 points |
| Q3 2025 | -19% | -20 points |
| Q2 2025 | -67% | -73 points |
| Q1 2025 | -12% | -6.1 points |
| Q4 2024 | -0.8% | +3.9 points |
PETS's operating margin was −18% last quarter, up 0.9 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over PETS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over PETS on profitability, with a higher operating margin.
PETS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6M | +$3.2M |
| Q2 2026 | -$8.3M | +$5.2M |
| Q1 2026 | -$5.5M | -218% |
| Q4 2025 | -$9.2M | -$7.2M |
| Q3 2025 | -$4.8M | -178% |
| Q2 2025 | -$13.6M | -$4.4M |
| Q1 2025 | $4.6M | -21% |
| Q4 2024 | -$1.9M | +$1.8M |
PETS has burned cash in seven of the last eight quarters: −$25M over the past year, against −$16M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over PETS on cash generation, producing positive trailing cash flow while its opponent burns cash.
PETS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.8% | -610K shares |
| 1 year | +0.9% | +183K shares |
| 3 years | +1.4% | +292K shares |
| 5 years | +2.5% | +504K shares |
| Available history | +5.4% | +1.1M shares |
PETS has 21M diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $1,000 |
| Q4 2019 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over PETS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
PETS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | -9.9x | Net Cash |
| Q4 2024 | -6.7x | Net Cash |
| Q3 2024 | -10.3x | Net Cash |
| Q2 2024 | -8.4x | Net Cash |
| Q4 2023 | -22.5x | Net Cash |
| Q3 2023 | -14.6x | Net Cash |
| Q2 2023 | -12.6x | Net Cash |
| Q1 2023 | -10.9x | Net Cash |
PETS has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
PETS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 23.8 | Oversold |
| Stochastic | 5.8 | Oversold |
PETS's weekly RSI is 24 (oversold) and its Stochastic is 6 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
PETS PE vs Healthcare Sector
| Metric | PETS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
PETS has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
PETS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.25 | 21% below |
| 20 week MA | $1.62 | 39% below |
| 50 week MA | $2.19 | 55% below |
| 100 week MA | $2.86 | 65% below |
| 200 week MA | $5.88 | 83% below |
PETS is in a downtrend: it's below all five of its weekly moving averages, and 83% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over PETS on trend strength, trading above more of its moving averages.
PETS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.1 | $33.8 | +46% |
| 2021 | $33.8 | $26.4 | -22% |
| 2022 | $26.4 | $18.1 | -31% |
| 2023 | $18.1 | $7.56 | -58% |
| 2024 | $7.56 | $5.16 | -32% |
| 2025 | $5.16 | $3.47 | -33% |
| 2026 YTD | $3.47 | $0.99 | -71% |
PETS has finished five years in a row lower, and it's down 71% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over PETS on returns for 2026, with the stronger performance.